Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 1;406(1):112734.
doi: 10.1016/j.yexcr.2021.112734. Epub 2021 Jul 13.

Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers

Shan Yu  1 , Qian Li  2 , Yan Wang  3 , Yuehong Cui  4 , Yiyi Yu  5 , Wei Li  6 , Fenglin Liu  7 , Tianshu Liu  8
Affiliations

Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers

Shan Yu et al. Exp Cell Res. .

Abstract

Chemotherapy is the preferred clinical treatment for advanced stage gastric cancer (GC) patients, of which efficacy could be markedly impaired due to the development of chemoresistance. Alternatively activated or M2-type tumor associated macrophages (TAMs) are recruited under chemotherapy and are highly implicated in the chemoresistance development, but underlying molecular mechanism for TAM activation is largely unknown. Here, we present that tumor-derived Leukemia inhibitory factor (LIF) induced by chemo drugs represses the chemo sensitivity of gastric tumor cells in a TAM-dependent manner. Mechanistically, cisplatin-induced HIF1α signaling activation directly drive the transcription of LIF, which promotes the resistance of gastric tumors to chemo drug. Further study revealed that tumor cell-derived LIF stimulates macrophages into tumor-supporting M2-type phenotype via activating STAT3 signaling pathway. Therapeutically, blocking LIF efficiently elevates chemo sensitivity of tumor cells and further represses the growth rates of tumors under chemotherapy. Therefore, our study reveals a novel insight in understanding the cross talking between tumor cells and immune cells and provides new therapeutic targets for gastric cancer.

Keywords: Chemoresistance; Gastric cancer; HIF1α; Leukemia inhibitory factor; Tumor associated macrophage.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms